{"DataElement":{"publicId":"2199412","version":"1","preferredName":"Brain Tumor Histology Name","preferredDefinition":"Brain tumor histologic term.","longName":"BRAI_TUM_HIST_NM","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2188996","version":"1","preferredName":"Brain Tumor Histologic Classification","preferredDefinition":"information related to histologic category or classification of a brain tumor.","longName":"BRAI_TUMO_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206623","version":"1","preferredName":"Brain Neoplasm","preferredDefinition":"That part of the central nervous system contained within the cranium, comprising the prosencephalon, mesencephalon, and rhombencephalon. It is derived from the anterior part of the embryonic neural tube. Functions include muscle control and coordination, sensory reception and integration, speech production, memory storage, and the elaboration of thought and emotions.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12439:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FCF8-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5CB1E3F-2BA5-3FA0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2199410","version":"1","preferredName":"Brain Tumor Histology Name","preferredDefinition":"Brain tumor diagnostic names using terms from the WHO and ICD-03 vocabularies","longName":"BRAI_TUM_HIST_NM","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"120","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Anaplastic astrocytoma","valueDescription":"Anaplastic astrocytoma","ValueMeaning":{"publicId":"2572930","version":"1","preferredName":"Anaplastic astrocytoma","longName":"2572930","preferredDefinition":"A diffusely infiltrating, WHO grade III astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astrocytoma","conceptCode":"C9477","definition":"A diffusely infiltrating, WHO grade 3 astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9EF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-011E-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic ependymoma","valueDescription":"Anaplastic ependymoma","ValueMeaning":{"publicId":"2572931","version":"1","preferredName":"Anaplastic ependymoma","longName":"2572931","preferredDefinition":"Anaplastic Ependymoma (WHO grade III) is a malignant glioma of ependymal origin with accelerated growth and an unfavorable clinical outcome, particularly in children. Anaplastic Ependymomas show high mitotic activity, often accompanied by microvascular proliferation and pseudo-palisading necrosis. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Ependymoma","conceptCode":"C4049","definition":"A WHO grade 3 malignant glioma of ependymal origin with accelerated growth and an unfavorable clinical outcome, particularly in children. It is characterized by high mitotic activity, often accompanied by microvascular proliferation and pseudo-palisading necrosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-011F-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic ganglioglioma","valueDescription":"Anaplastic ganglioglioma","ValueMeaning":{"publicId":"2572932","version":"1","preferredName":"Anaplastic ganglioglioma","longName":"2572932","preferredDefinition":"Anaplastic Ganglioglioma (WHO grade III) is a neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and anaplastic glial cells. These anaplastic changes in the glial component and high MIB-1 and TP53 labelling indices may indicate aggressive behavior.  However, the correlation of histological anaplasia with clinical outcome is inconsistent. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Ganglioglioma","conceptCode":"C4717","definition":"A WHO grade III neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and anaplastic glial cells. The anaplastic changes in the glial component and high MIB-1 and TP53 labeling indices may indicate aggressive behavior. However, the correlation of histological anaplasia with clinical outcome is inconsistent. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0120-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic meningioma","valueDescription":"Anaplastic meningioma","ValueMeaning":{"publicId":"2568666","version":"1","preferredName":"Anaplastic meningioma","longName":"2568666","preferredDefinition":"Anaplastic meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D947-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0121-0048-E034-0003BA3F9857","beginDate":"2004-03-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic oligoastrocytoma","valueDescription":"Anaplastic oligoastrocytoma","ValueMeaning":{"publicId":"2568646","version":"1","preferredName":"Anaplastic oligoastrocytoma","longName":"2568646","preferredDefinition":"Anaplastic Oligoastrocytoma is an Oligoastrocytoma with histological features of malignancy, such as increased cellularity, nuclear atypia, pleomorphism, and increased mitotic activity. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligoastrocytoma","conceptCode":"C6959","definition":"An oligoastrocytoma characterized by the presence of increased cellularity, nuclear atypia, pleomorphism, and high mitotic activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D933-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0122-0048-E034-0003BA3F9857","beginDate":"2004-03-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic oligodendroglioma","valueDescription":"Anaplastic oligodendroglioma","ValueMeaning":{"publicId":"2572933","version":"1","preferredName":"Anaplastic oligodendroglioma","longName":"2572933","preferredDefinition":"A WHO grade III oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligodendroglioma","conceptCode":"C4326","definition":"A WHO grade 3 oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0123-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Angiolipoma","valueDescription":"Angiolipoma","ValueMeaning":{"publicId":"2572934","version":"1","preferredName":"Angiolipoma","longName":"2572934","preferredDefinition":"Angiolipoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0124-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Angiosarcoma","valueDescription":"Angiosarcoma","ValueMeaning":{"publicId":"2568840","version":"1","preferredName":"Angiosarcoma","longName":"2568840","preferredDefinition":"A malignant tumor arising from the endothelial cells of the blood vessels.  Microscopically, it is characterized by frequently open vascular anastomosing and branching channels.  The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei.  Angiosarcomas most frequently occur in the skin and breast.  Patients with long-standing lymphedema are at increased risk of developing angiosarcoma. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angiosarcoma","conceptCode":"C3088","definition":"A malignant tumor arising from the endothelial cells of the blood vessels.  Microscopically, it is characterized by frequently open vascular anastomosing and branching channels.  The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei.  Angiosarcomas most frequently occur in the skin and breast.  Patients with long-standing lymphedema are at increased risk of developing angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"CAMPBELB","dateModified":"2007-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0125-0048-E034-0003BA3F9857","beginDate":"2004-03-29","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Astroblastoma","valueDescription":"Astroblastoma","ValueMeaning":{"publicId":"2578712","version":"1","preferredName":"Astroblastoma","longName":"2578712","preferredDefinition":"Astroblastoma is a rare glial neoplasm more commonly found in young adults. It is characterized by tumor cells with characteristics suggestive of an astrocytic origin (positive for GFAP), arranged perivascularly. The cells have broad, non-tapering processes radiating towards a central blood vessel. The biologic behavior of astroblastomas is variable, so no WHO grade has been established, yet. (Adapted from WHO.) NCIPDQ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Astroblastoma, MN1-Altered","conceptCode":"C4324","definition":"A rare glial neoplasm characterized by structural rearrangements of the MN1 gene at chromosome band 22q12.1. It is usually found in the cerebral hemispheres of young adults and children and predominantly affects females. Morphologically, it consists of elongated glial cells with abundant eosinophilic cytoplasm and GFAP-positive processes, arranged perivascularly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0085-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SOKKERL","dateModified":"2024-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0126-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Central neurocytoma","valueDescription":"Central neurocytoma","ValueMeaning":{"publicId":"2578719","version":"1","preferredName":"Central neurocytoma","longName":"2578719","preferredDefinition":"Central Neurocytoma is an intraventricular neuronal neoplasm composed of uniform round cells with neuronal differentiation. It is typically located in the lateral ventricles in the region of the foramen of Monro.  It generally affects young adults and has a favorable prognosis. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Neurocytoma","conceptCode":"C3791","definition":"An intraventricular neuronal neoplasm composed of uniform round cells with neuronal differentiation. It is typically located in the lateral ventricles in the region of the foramen of Monro. It generally affects young adults and has a favorable prognosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-008C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SOKKERL","dateModified":"2024-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0129-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Cerebellar liponeurocytoma","valueDescription":"Cerebellar liponeurocytoma","ValueMeaning":{"publicId":"2578720","version":"1","preferredName":"Cerebellar liponeurocytoma","longName":"2578720","preferredDefinition":"Cerebellar Liponeurocytoma (WHO grade I or II) is a rare cerebellar neoplasm which shows advanced neuronal/neurocytic and focal lipomatous differentiation. It occurs in adults, has a low proliferative potential and has a favorable clinical prognosis. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cerebellar Liponeurocytoma","conceptCode":"C6905","definition":"A rare, WHO grade II cerebellar neoplasm which shows consistent neuronal, variable astrocytic and focal lipomatous differentiation. It occurs in adults, has a low proliferative potential and usually has a favorable prognosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-008D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-012A-0048-E034-0003BA3F9857","beginDate":"2004-03-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Chondroma","valueDescription":"Chondroma","ValueMeaning":{"publicId":"2572937","version":"1","preferredName":"Chondroma","longName":"2572937","preferredDefinition":"A benign well circumscribed neoplasm of hyaline cartilage arising from bone or soft tissue. It is characterized by the presence of chondrocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chondroma","conceptCode":"C53459","definition":"A benign well circumscribed neoplasm of hyaline cartilage arising from bone or soft tissue. It is characterized by the presence of chondrocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2016-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-012B-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Chondrosarcoma","valueDescription":"Chondrosarcoma","ValueMeaning":{"publicId":"2568862","version":"1","preferredName":"Chondrosarcoma","longName":"2568862","preferredDefinition":"Chondrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA0B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-012C-0048-E034-0003BA3F9857","beginDate":"2004-03-29","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Chordoid glioma of the third ventricle","valueDescription":"Chordoid glioma of the third ventricle","ValueMeaning":{"publicId":"2568647","version":"1","preferredName":"Chordoid glioma of the third ventricle","longName":"2568647","preferredDefinition":"Chordoid Glioma of the 3rd Ventricle is a rare, slow growing, glial tumor located in the third ventricle of adults. It is characterized histologically by clusters and cords of epithelioid, GFAP expressing tumor cells within a stroma with varying amounts of mucin, which typically contains a lymphoplasmacytic infiltrate. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chordoid Glioma of the Third Ventricle","conceptCode":"C6961","definition":"Chordoid Glioma of the 3rd Ventricle is a rare, slow growing, glial tumor located in the third ventricle of adults. It is characterized histologically by clusters and cords of epithelioid, GFAP expressing tumor cells within a stroma with varying amounts of mucin, which typically contains a lymphoplasmacytic infiltrate. (Adapted from WHO.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D934-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-012D-0048-E034-0003BA3F9857","beginDate":"2004-03-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Choriocarcinoma","valueDescription":"Choriocarcinoma","ValueMeaning":{"publicId":"2574079","version":"1","preferredName":"Choriocarcinoma","longName":"2574079","preferredDefinition":"An aggressive malignant tumor arising from trophoblastic cells.  The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells.  Approximately half of the cases develop from a complete hydatidiform mole.  A minority of cases arise in the testis or the ovaries.  There is often marked elevation of human chorionic gonadotropin (hCG) in the blood.  Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choriocarcinoma","conceptCode":"C2948","definition":"An aggressive malignant tumor arising from trophoblastic cells. The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells. Approximately half of the cases develop from a complete hydatidiform mole. A minority of cases arise in the testis or the ovaries. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE6C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Added missing system generated definition for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-012E-0048-E034-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Choroid plexus carcinoma","valueDescription":"Choroid plexus carcinoma","ValueMeaning":{"publicId":"2578711","version":"1","preferredName":"Choroid plexus carcinoma","longName":"2578711","preferredDefinition":"Choroid Plexus Carcinoma (WHO grade III) is a malignant Choroid Plexus Tumor which shows anaplastic features and usually invades neighboring brain structures. CSF metastases are frequent. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choroid Plexus Carcinoma","conceptCode":"C4715","definition":"A malignant neoplasm arising from the choroid plexus.  It shows anaplastic features and usually invades neighboring brain structures. Cerebrospinal fluid metastases are frequent. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0084-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-012F-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Choroid plexus papilloma","valueDescription":"Choroid Plexus Papilloma","ValueMeaning":{"publicId":"2572938","version":"1","preferredName":"Choroid Plexus Papilloma","longName":"2572938","preferredDefinition":"Choroid Plexus Papilloma (WHO grade I) is a benign, slow growing tumor which may cause symptoms by blocking CSF pathways. Surgical resection is usually curative. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choroid Plexus Papilloma","conceptCode":"C3698","definition":"A benign, slow growing tumor which may cause symptoms by blocking cerebrospinal fluid pathways.  It is characterized by the presence of delicate fibrovascular connective tissue fronds covered by a single layer of epithelial cells.  Mitotic activity is extremely low.  Surgical resection is usually curative. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0130-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Craniopharyngioma, adamantinomatous variant","valueDescription":"Craniopharyngioma, adamantinomatous variant","ValueMeaning":{"publicId":"2572939","version":"1","preferredName":"Craniopharyngioma, adamantinomatous variant","longName":"2572939","preferredDefinition":"Craniopharyngioma, adamantinomatous variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0131-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Craniopharyngioma, papillary variant","valueDescription":"Craniopharyngioma, papillary variant","ValueMeaning":{"publicId":"2572940","version":"1","preferredName":"Craniopharyngioma, papillary variant","longName":"2572940","preferredDefinition":"Craniopharyngioma, papillary variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0133-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Desmoplastic infantile astrocytoma/ganglioglioma","valueDescription":"Desmoplastic infantile astrocytoma/ganglioglioma","ValueMeaning":{"publicId":"2572941","version":"1","preferredName":"Desmoplastic infantile astrocytoma/ganglioglioma","longName":"2572941","preferredDefinition":"Desmoplastic infantile astrocytoma/ganglioglioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9FA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0134-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Diffuse astrocytoma, fibrillary variant","valueDescription":"Diffuse astrocytoma, fibrillary variant","ValueMeaning":{"publicId":"2572942","version":"1","preferredName":"Diffuse astrocytoma, fibrillary variant","longName":"2572942","preferredDefinition":"Diffuse astrocytoma, fibrillary variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9FB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0135-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Diffuse astrocytoma, gemistocytic variant","valueDescription":"Diffuse astrocytoma, gemistocytic variant","ValueMeaning":{"publicId":"2572943","version":"1","preferredName":"Diffuse astrocytoma, gemistocytic variant","longName":"2572943","preferredDefinition":"Diffuse astrocytoma, gemistocytic variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9FC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0136-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Diffuse astrocytoma, protoplasmic variant","valueDescription":"Diffuse astrocytoma, protoplasmic variant","ValueMeaning":{"publicId":"2572944","version":"1","preferredName":"Diffuse astrocytoma, protoplasmic variant","longName":"2572944","preferredDefinition":"Diffuse astrocytoma, protoplasmic variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9FD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01BE-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Diffuse melanocytosis","valueDescription":"Diffuse melanocytosis","ValueMeaning":{"publicId":"2572945","version":"1","preferredName":"Diffuse melanocytosis","longName":"2572945","preferredDefinition":"Diffuse melanocytosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9FE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01BF-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Dysembryoplastic neuroepithelial tumor","valueDescription":"Dysembryoplastic Neuroepithelial Tumor","ValueMeaning":{"publicId":"2578718","version":"1","preferredName":"Dysembryoplastic Neuroepithelial Tumor","longName":"2578718","preferredDefinition":"Dysembryoplastic Neuroepithelial Tumor (WHO grade I) is a benign glial-neuronal neoplasm. It is usually supratentorial, located, generally, in the cortex and occurs in children and young adults with a long-standing history of partial seizures. A histologic hallmark of this tumor is the 'specific glioneuronal element', characterized by columns, made up of bundles of axons, oriented perpendicularly to the cortical surface. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dysembryoplastic Neuroepithelial Tumor","conceptCode":"C9505","definition":"A glial-neuronal neoplasm located in the cortex. It occurs in children and young adults with a long-standing history of partial seizures. A histologic hallmark of this tumor is the 'specific glioneuronal element', characterized by columns, made up of bundles of axons, oriented perpendicularly to the cortical surface. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-008B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01C0-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Dysplastic gangliocytoma of cerebellum","valueDescription":"Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)","ValueMeaning":{"publicId":"2572946","version":"1","preferredName":"Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)","longName":"2572946","preferredDefinition":"Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9FF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01C1-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Embryonal carcinoma","valueDescription":"Embryonal carcinoma","ValueMeaning":{"publicId":"2567194","version":"1","preferredName":"Embryonal carcinoma","longName":"2567194","preferredDefinition":"A non-seminomatous malignant germ cell tumor characterized by the presence of large germ cells with abundant cytoplasm resembling epithelial cells, geographic necrosis, high mitotic activity, and pseudoglandular and pseudopapillary structures formation. It can arise from the testis, ovary, and extragonadal sites (central nervous system and mediastinum).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Carcinoma","conceptCode":"C3752","definition":"A non-seminomatous malignant germ cell tumor characterized by the presence of large germ cells with abundant cytoplasm resembling epithelial cells, geographic necrosis, high mitotic activity, and pseudoglandular and pseudopapillary structures formation. It can arise from the testis, ovary, and extragonadal sites (central nervous system and mediastinum).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D387-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Added missing system generated definition. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01C2-0048-E034-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Ependymoblastoma","valueDescription":"Ependymoblastoma","ValueMeaning":{"publicId":"2568654","version":"1","preferredName":"Ependymoblastoma","longName":"2568654","preferredDefinition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is characterized by the presence of multilayered rosettes formation, and increased cellularity. Symptoms include increased intracranial pressure, hydrocephalus, and focal neurological signs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered","conceptCode":"C4915","definition":"An aggressive embryonal tumor with multilayered rosettes characterized by the presence of amplification of the C19MC region on chromosome 19 (19q13.42).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01C4-0048-E034-0003BA3F9857","beginDate":"2004-03-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ependymoma, cellular variant","valueDescription":"Ependymoma, cellular variant","ValueMeaning":{"publicId":"2572948","version":"1","preferredName":"Ependymoma, cellular variant","longName":"2572948","preferredDefinition":"Ependymoma, cellular variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA01-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01C5-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ependymoma, clear cell variant","valueDescription":"Ependymoma, clear cell variant","ValueMeaning":{"publicId":"2572949","version":"1","preferredName":"Ependymoma, clear cell variant","longName":"2572949","preferredDefinition":"Ependymoma, clear cell variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA02-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01C6-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ependymoma, papillary variant","valueDescription":"Ependymoma, papillary variant","ValueMeaning":{"publicId":"2572950","version":"1","preferredName":"Ependymoma, papillary variant","longName":"2572950","preferredDefinition":"Ependymoma, papillary variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA03-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01C8-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ependymoma, tanycytic variant","valueDescription":"Ependymoma, tanycytic variant","ValueMeaning":{"publicId":"2572951","version":"1","preferredName":"Ependymoma, tanycytic variant","longName":"2572951","preferredDefinition":"Ependymoma, tanycytic variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA04-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01C9-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Fibrosarcoma","valueDescription":"Fibrosarcoma","ValueMeaning":{"publicId":"2568825","version":"1","preferredName":"Fibrosarcoma","longName":"2568825","preferredDefinition":"A malignant mesenchymal tumor affecting soft tissues and bone. It is classified as adult or infantile.  Infantile fibrosarcomas generally have a much more favorable prognosis than adult fibrosarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosarcoma","conceptCode":"C3043","definition":"A malignant mesenchymal fibroblastic neoplasm affecting the soft tissue and bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"CAMPBELB","dateModified":"2007-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01CB-0048-E034-0003BA3F9857","beginDate":"2004-03-29","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Gangliocytoma","valueDescription":"Gangliocytoma","ValueMeaning":{"publicId":"2578713","version":"1","preferredName":"Gangliocytoma","longName":"2578713","preferredDefinition":"Gangliocytoma (WHO grade I) and Ganglioglioma (WHO grade I or II) are well differentiated, slow growing neuroepithelial neoplasms composed of neoplastic, mature ganglion cells either alone (gangliocytoma), or in combination with neoplastic glial cells (ganglioglioma). (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gangliocytoma","conceptCode":"C6934","definition":"A well differentiated, slow growing neuroepithelial neoplasm composed of neoplastic, mature ganglion cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0086-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01CC-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ganglioglioma","valueDescription":"Ganglioglioma","ValueMeaning":{"publicId":"2578714","version":"1","preferredName":"Ganglioglioma","longName":"2578714","preferredDefinition":"Ganglioglioma (WHO grade I or II) and Gangliocytoma (WHO grade I) are well differentiated, slow growing neuroepithelial neoplasms composed of neoplastic, mature ganglion cells either alone (gangliocytoma), or in combination with neoplastic glial cells (ganglioglioma). Some Gangliogliomas show anaplastic features in their glial component and are considered to be WHO grade III (see 'Anaplastic Ganglioglioma). There are rare cases of newly diagnosed Gangliogliomas with grade IV (Glioblastoma) changes in the glial component. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ganglioglioma","conceptCode":"C3788","definition":"A well differentiated, slow growing neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and neoplastic glial cells. Some gangliogliomas show anaplastic features in their glial component and are considered to be WHO grade III. Rare cases of newly diagnosed gangliogliomas with grade IV (glioblastoma) changes in the glial component have also been reported. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0087-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01CD-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Germinoma","valueDescription":"Germinoma","ValueMeaning":{"publicId":"2578733","version":"1","preferredName":"Germinoma","longName":"2578733","preferredDefinition":"The most common type of germ cell tumor affecting the central nervous system.  It is composed of uniform cells with large vesicular nuclei, prominent nucleoli and clear cytoplasm.  Lymphocytic or lymphoplasmacytic infiltrates are usually seen admixed with the tumor cells.  Less frequently giant syncytiotrophoblastic cells are also present.  Germinomas are usually radiosensitive and they have a favorable prognosis.  - 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germinoma","conceptCode":"C3753","definition":"A malignant germ cell tumor arising in the central nervous system. It is characterized by the presence of primitive, large malignant germ cells and lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-009A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01CE-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Glioblastoma (multiforme), giant cell glioblastoma variant","valueDescription":"Glioblastoma (multiforme), giant cell glioblastoma variant","ValueMeaning":{"publicId":"2572954","version":"1","preferredName":"Glioblastoma (multiforme), giant cell glioblastoma variant","longName":"2572954","preferredDefinition":"Glioblastoma (multiforme), giant cell glioblastoma variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA07-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01D0-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Glioblastoma (multiforme), gliosarcoma variant","valueDescription":"Glioblastoma (multiforme), gliosarcoma variant","ValueMeaning":{"publicId":"2572955","version":"1","preferredName":"Glioblastoma (multiforme), gliosarcoma variant","longName":"2572955","preferredDefinition":"Glioblastoma (multiforme), gliosarcoma variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA08-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01D1-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Gliomatosis cerebri","valueDescription":"Gliomatosis cerebri","ValueMeaning":{"publicId":"2578735","version":"1","preferredName":"Gliomatosis cerebri","longName":"2578735","preferredDefinition":"Gliomatosis cerebri (WHO grade II) is a diffuse glial tumor which infiltrates the brain, extensively, involving more than two lobes. It is frequently bilateral and often extends to the infratentorial structures, even to the spinal cord. It is probably of astrocytic origin, although GFAP expression may be scant or absent. (Adapted form WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gliomatosis Cerebri","conceptCode":"C4318","definition":"A diffuse glial tumor which infiltrates the brain extensively, involving more than two lobes. It is frequently bilateral and often extends to the infratentorial structures, even to the spinal cord. It is probably of astrocytic origin, although GFAP expression may be scant or absent. (Adapted from WHO.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-009C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01D3-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Granular cell tumor","valueDescription":"Granular cell tumor","ValueMeaning":{"publicId":"2578729","version":"1","preferredName":"Granular cell tumor","longName":"2578729","preferredDefinition":"Unusual tumor affecting any site of the body, but most often encountered in the head and neck. Considerable debate has surrounded the histogenesis of this neoplasm; it usually has a benign nature. It affects women more often than men. When it develops beneath the epidermis or mucous membrane, it can lead to proliferation of the squamous cells and mimic squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granular Cell Tumor","conceptCode":"C3474","definition":"An unusual benign or malignant neoplasm characterized by the presence of neoplastic large polygonal cells with granular, eosinophilic cytoplasm which contains abundant lysosomes. It was originally thought to be a tumor originating from muscle cells and was named granular cell myoblastoma. Subsequent studies have suggested a derivation from Schwann cells. It affects females more often than males and it usually presents as a solitary mass. A minority of patients have multiple tumors. It can arise from many anatomic sites including the posterior pituitary gland, skin, oral cavity, esophagus, stomach, heart, mediastinum, and breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0096-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01D4-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Granulocytic sarcoma","valueDescription":"Myeloid Sarcoma","ValueMeaning":{"publicId":"2572957","version":"1","preferredName":"Myeloid Sarcoma","longName":"2572957","preferredDefinition":"A tumor mass composed of myeloblasts or immature myeloid cells.  It occurs in extramedullary sites or the bone.  (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myeloid Sarcoma","conceptCode":"C3520","definition":"A tumor mass composed of myeloblasts or immature myeloid cells.  It occurs in extramedullary sites or the bone.  (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA0A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2016-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01D5-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Hemangioblastoma","valueDescription":"Hemangioblastoma","ValueMeaning":{"publicId":"2572958","version":"1","preferredName":"Hemangioblastoma","longName":"2572958","preferredDefinition":"Hemangioblastoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA0B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-01D6-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Hemangioma","valueDescription":"Hemangioma","ValueMeaning":{"publicId":"2572959","version":"1","preferredName":"Hemangioma","longName":"2572959","preferredDefinition":"Hemangioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA0C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0249-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Hemangiopericytoma","valueDescription":"Hemangiopericytoma","ValueMeaning":{"publicId":"2572960","version":"1","preferredName":"Hemangiopericytoma","longName":"2572960","preferredDefinition":"Hemangiopericytoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA0D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-024A-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Hibernoma","valueDescription":"Hibernoma","ValueMeaning":{"publicId":"2572961","version":"1","preferredName":"Hibernoma","longName":"2572961","preferredDefinition":"Hibernoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA0E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-024B-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Kaposi sarcoma","valueDescription":"Kaposi sarcoma","ValueMeaning":{"publicId":"2568842","version":"1","preferredName":"Kaposi sarcoma","longName":"2568842","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"UMLLOADER_COPPAPRD","dateModified":"2009-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B8C3-1CE0-E034-0003BA3F9857","beginDate":"2004-03-29","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Leiomyoma","valueDescription":"Leiomyoma","ValueMeaning":{"publicId":"2572962","version":"1","preferredName":"Leiomyoma","longName":"2572962","preferredDefinition":"Leiomyoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA0F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B8C4-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Leiomyosarcoma","valueDescription":"Leiomyosarcoma","ValueMeaning":{"publicId":"2562491","version":"1","preferredName":"Leiomyosarcoma","longName":"2562491","preferredDefinition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women. It is characterized by a proliferation of neoplastic spindle cells. Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leiomyosarcoma","conceptCode":"C3158","definition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women.  It is characterized by a proliferation of neoplastic spindle cells.  Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C128-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-09-27","endDate":null,"createdBy":"PWEST","dateCreated":"2002-09-27","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B8C5-1CE0-E034-0003BA3F9857","beginDate":"2002-09-27","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Lipoma","valueDescription":"Lipoma","ValueMeaning":{"publicId":"2572963","version":"1","preferredName":"Lipoma","longName":"2572963","preferredDefinition":"Lipoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA10-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B8C6-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Liposarcoma (intracranial)","valueDescription":"Liposarcoma (intracranial)","ValueMeaning":{"publicId":"2572964","version":"1","preferredName":"Liposarcoma (intracranial)","longName":"2572964","preferredDefinition":"Liposarcoma (intracranial)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA11-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B8C7-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Malignant fibrous histiocytoma","valueDescription":"Malignant fibrous histiocytoma","ValueMeaning":{"publicId":"2572965","version":"1","preferredName":"Malignant fibrous histiocytoma","longName":"2572965","preferredDefinition":"An undifferentiated soft tissue sarcoma characterized by the presence of a pleomorphic malignant cellular infiltrate.  It is also known as malignant fibrous histiocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Pleomorphic Sarcoma","conceptCode":"C4247","definition":"An undifferentiated soft tissue sarcoma characterized by the presence of a pleomorphic malignant cellular infiltrate.  It is also known as malignant fibrous histiocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA12-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2016-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B8C8-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Malignant melanoma","valueDescription":"Malignant melanoma","ValueMeaning":{"publicId":"2572967","version":"1","preferredName":"Malignant melanoma","longName":"2572967","preferredDefinition":"Malignant melanoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA14-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B8CA-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"MPNST, epitheliod variant","valueDescription":"Malignant peripheral nerve sheath tumor (MPNST), epitheliod variant","ValueMeaning":{"publicId":"2572968","version":"1","preferredName":"Malignant peripheral nerve sheath tumor (MPNST), epitheliod variant","longName":"2572968","preferredDefinition":"Malignant peripheral nerve sheath tumor (MPNST), epitheliod variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B8CB-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"MPNST, melanotic psammomatous variant","valueDescription":"Malignant peripheral nerve sheath tumor (MPNST), melanotic psammomatous variant","ValueMeaning":{"publicId":"2572969","version":"1","preferredName":"Malignant peripheral nerve sheath tumor (MPNST), melanotic psammomatous variant","longName":"2572969","preferredDefinition":"Malignant peripheral nerve sheath tumor (MPNST), melanotic psammomatous variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA16-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B8CC-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"MPNST, melanotic variant","valueDescription":"Malignant peripheral nerve sheath tumor (MPNST), melanotic variant","ValueMeaning":{"publicId":"2572970","version":"1","preferredName":"Malignant peripheral nerve sheath tumor (MPNST), melanotic variant","longName":"2572970","preferredDefinition":"Malignant peripheral nerve sheath tumor (MPNST), melanotic variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA17-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-030B-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"MPNST, w/ divergent mesench and/or epith diff variant","valueDescription":"Malignant peripheral nerve sheath tumor (MPNST), with divergent mesenchymal and/or epithelial differentiation variant","ValueMeaning":{"publicId":"2572972","version":"1","preferredName":"Malignant peripheral nerve sheath tumor (MPNST), with divergent mesenchymal and/or epithelial differentiation variant","longName":"2572972","preferredDefinition":"Malignant peripheral nerve sheath tumor (MPNST), with divergent mesenchymal and/or epithelial differentiation variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA19-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-030D-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medulloblastoma, desmoplastic medulloblastoma variant","valueDescription":"Medulloblastoma, desmoplastic medulloblastoma variant","ValueMeaning":{"publicId":"2572973","version":"1","preferredName":"Medulloblastoma, desmoplastic medulloblastoma variant","longName":"2572973","preferredDefinition":"Medulloblastoma, desmoplastic medulloblastoma variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA1A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-030E-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medulloblastoma, large cell medulloblastoma variant","valueDescription":"Medulloblastoma, large cell medulloblastoma variant","ValueMeaning":{"publicId":"2572974","version":"1","preferredName":"Medulloblastoma, large cell medulloblastoma variant","longName":"2572974","preferredDefinition":"Medulloblastoma, large cell medulloblastoma variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA1B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-030F-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medulloblastoma, medullomyoblastoma variant","valueDescription":"Medulloblastoma, medullomyoblastoma variant","ValueMeaning":{"publicId":"2572975","version":"1","preferredName":"Medulloblastoma, medullomyoblastoma variant","longName":"2572975","preferredDefinition":"Medulloblastoma, medullomyoblastoma variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA1C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0310-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medulloblastoma, melanotic medulloblastoma variant","valueDescription":"Medulloblastoma, melanotic medulloblastoma variant","ValueMeaning":{"publicId":"2572976","version":"1","preferredName":"Medulloblastoma, melanotic medulloblastoma variant","longName":"2572976","preferredDefinition":"Medulloblastoma, melanotic medulloblastoma variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA1D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0311-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medulloepithelioma","valueDescription":"Medulloepithelioma","ValueMeaning":{"publicId":"2572977","version":"1","preferredName":"Medulloepithelioma","longName":"2572977","preferredDefinition":"Medulloepithelioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA1E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0313-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Melanocytoma","valueDescription":"Melanocytoma","ValueMeaning":{"publicId":"2572978","version":"1","preferredName":"Melanocytoma","longName":"2572978","preferredDefinition":"Melanocytoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA1F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0314-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningeal melanomatosis","valueDescription":"Meningeal melanomatosis","ValueMeaning":{"publicId":"2572979","version":"1","preferredName":"Meningeal melanomatosis","longName":"2572979","preferredDefinition":"Meningeal melanomatosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA20-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0315-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, angiomatous variant","valueDescription":"Meningioma, angiomatous variant","ValueMeaning":{"publicId":"2572980","version":"1","preferredName":"Meningioma, angiomatous variant","longName":"2572980","preferredDefinition":"Meningioma, angiomatous variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA21-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0316-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, atypical variant","valueDescription":"Meningioma, atypical variant","ValueMeaning":{"publicId":"2572981","version":"1","preferredName":"Meningioma, atypical variant","longName":"2572981","preferredDefinition":"Meningioma, atypical variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA22-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0317-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, chordoid variant","valueDescription":"Meningioma, chordoid variant","ValueMeaning":{"publicId":"2572982","version":"1","preferredName":"Meningioma, chordoid variant","longName":"2572982","preferredDefinition":"Meningioma, chordoid variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA23-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0318-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, clear cell variant","valueDescription":"Meningioma, clear cell variant","ValueMeaning":{"publicId":"2572983","version":"1","preferredName":"Meningioma, clear cell variant","longName":"2572983","preferredDefinition":"Meningioma, clear cell variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA24-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0319-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, fibrous variant","valueDescription":"Meningioma, fibrous (fibroblastic) variant","ValueMeaning":{"publicId":"2572984","version":"1","preferredName":"Meningioma, fibrous (fibroblastic) variant","longName":"2572984","preferredDefinition":"Meningioma, fibrous (fibroblastic) variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA25-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-031A-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, lymphoplasmacyte-rich variant","valueDescription":"Meningioma, lymphoplasmacyte-rich variant","ValueMeaning":{"publicId":"2572985","version":"1","preferredName":"Meningioma, lymphoplasmacyte-rich variant","longName":"2572985","preferredDefinition":"Meningioma, lymphoplasmacyte-rich variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA26-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-031B-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, meningothelial variant","valueDescription":"Meningioma, meningothelial variant","ValueMeaning":{"publicId":"2572986","version":"1","preferredName":"Meningioma, meningothelial variant","longName":"2572986","preferredDefinition":"Meningioma, meningothelial variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA27-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-031C-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, metaplastic variant","valueDescription":"Meningioma, metaplastic variant","ValueMeaning":{"publicId":"2572987","version":"1","preferredName":"Meningioma, metaplastic variant","longName":"2572987","preferredDefinition":"Meningioma, metaplastic variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA28-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-031D-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, microcystic variant","valueDescription":"Meningioma, microcystic variant","ValueMeaning":{"publicId":"2572988","version":"1","preferredName":"Meningioma, microcystic variant","longName":"2572988","preferredDefinition":"Meningioma, microcystic variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA29-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-031E-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, papillary variant","valueDescription":"Meningioma, papillary variant","ValueMeaning":{"publicId":"2572990","version":"1","preferredName":"Meningioma, papillary variant","longName":"2572990","preferredDefinition":"Meningioma, papillary variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA2B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0320-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, psammomatous variant","valueDescription":"Meningioma, psammomatous variant","ValueMeaning":{"publicId":"2572991","version":"1","preferredName":"Meningioma, psammomatous variant","longName":"2572991","preferredDefinition":"Meningioma, psammomatous variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA2C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0321-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, rhabdoid variant","valueDescription":"Meningioma, rhabdoid variant","ValueMeaning":{"publicId":"2572992","version":"1","preferredName":"Meningioma, rhabdoid variant","longName":"2572992","preferredDefinition":"Meningioma, rhabdoid variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA2D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0322-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, secretory variant","valueDescription":"Meningioma, secretory variant","ValueMeaning":{"publicId":"2572993","version":"1","preferredName":"Meningioma, secretory variant","longName":"2572993","preferredDefinition":"Meningioma, secretory variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA2E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0323-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, transitional variant","valueDescription":"Meningioma, transitional (mixed) variant","ValueMeaning":{"publicId":"2572994","version":"1","preferredName":"Meningioma, transitional (mixed) variant","longName":"2572994","preferredDefinition":"Meningioma, transitional (mixed) variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA2F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0324-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Mixed germ cell tumor","valueDescription":"Mixed germ cell tumor","ValueMeaning":{"publicId":"2566026","version":"1","preferredName":"Mixed germ cell tumor","longName":"2566026","preferredDefinition":"Mixed germ cell tumor","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Germ Cell Tumor","conceptCode":"C4285","definition":"Definition not available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEF7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-0327-0048-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Myxopapillary ependymoma","valueDescription":"Myxopapillary ependymoma","ValueMeaning":{"publicId":"2578709","version":"1","preferredName":"Myxopapillary ependymoma","longName":"2578709","preferredDefinition":"Myxopapillary Ependymomas (WHO grade I) are slow growing gliomas which generally occur in young adults and arise almost exclusively in the conus-cauda-filum terminale region. It generally has a favorable prognosis and is characterized histologically by tumor cells arranged in a papillary manner around vascularized mucoid stromal cores. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxopapillary Ependymoma","conceptCode":"C3697","definition":"A slow growing, WHO grade I glioma which generally occurs in young adults.  It arises almost exclusively in the conus medullaris, cauda equina, and filum terminale of the spinal cord. It generally has a favorable prognosis and is characterized histologically by tumor cells arranged in a papillary manner around vascularized mucoid stromal cores. (Adapted from WHO).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0082-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B9FC-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Neuroblastomas of the adrenal gland and SNS","valueDescription":"Neuroblastomas of the adrenal gland and sympathetic nervous system","ValueMeaning":{"publicId":"2568652","version":"1","preferredName":"Neuroblastomas of the adrenal gland and sympathetic nervous system","longName":"2568652","preferredDefinition":"Neuroblastomas of the adrenal gland and sympathetic nervous system","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D939-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-B9FE-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Neurofibroma, plexiform variant","valueDescription":"Neurofibroma, plexiform variant","ValueMeaning":{"publicId":"2572997","version":"1","preferredName":"Neurofibroma, plexiform variant","longName":"2572997","preferredDefinition":"Neurofibroma, plexiform variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA32-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA00-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Olfactory neuroblastoma","valueDescription":"Olfactory neuroblastoma (Aesthesioneuroblastoma)","ValueMeaning":{"publicId":"2572999","version":"1","preferredName":"Olfactory neuroblastoma (Aesthesioneuroblastoma)","longName":"2572999","preferredDefinition":"Olfactory neuroblastoma (Aesthesioneuroblastoma)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA34-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA02-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Olfactory neuroepithelioma","valueDescription":"Olfactory neuroepithelioma","ValueMeaning":{"publicId":"2573000","version":"1","preferredName":"Olfactory neuroepithelioma","longName":"2573000","preferredDefinition":"Smell; the faculty of smell, the sensation that results when olfactory receptors in the nose are stimulated by particular chemicals in gaseous form.: A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Olfaction","conceptCode":"C17139","definition":"The faculty of smell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Primitive Neuroectodermal Tumor","conceptCode":"C3716","definition":"A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA35-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concepts to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA03-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Oligoastrocytoma","valueDescription":"Oligoastrocytoma","ValueMeaning":{"publicId":"2568645","version":"1","preferredName":"Oligoastrocytoma","longName":"2568645","preferredDefinition":"A WHO grade II tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligoastrocytoma","conceptCode":"C4050","definition":"A WHO grade 2 tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA04-1CE0-E034-0003BA3F9857","beginDate":"2004-03-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Oligodendroglioma","valueDescription":"Oligodendroglioma","ValueMeaning":{"publicId":"2573001","version":"1","preferredName":"Oligodendroglioma","longName":"2573001","preferredDefinition":"Oligodendroglioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA36-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA05-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Osteochondrosarcoma","valueDescription":"Osteochondrosarcoma","ValueMeaning":{"publicId":"2573002","version":"1","preferredName":"Osteochondrosarcoma","longName":"2573002","preferredDefinition":"Osteochondrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA37-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA06-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Osteoma","valueDescription":"Osteoma","ValueMeaning":{"publicId":"2573003","version":"1","preferredName":"Osteoma","longName":"2573003","preferredDefinition":"Osteoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA38-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA07-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Osteosarcoma","valueDescription":"Osteosarcoma","ValueMeaning":{"publicId":"2573004","version":"1","preferredName":"Osteosarcoma","longName":"2573004","preferredDefinition":"A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteosarcoma","conceptCode":"C9145","definition":"A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA39-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA08-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Paraganglioma of the filum terminale","valueDescription":"Paraganglioma of the filum terminale","ValueMeaning":{"publicId":"2568651","version":"1","preferredName":"Paraganglioma of the filum terminale","longName":"2568651","preferredDefinition":"An extra-adrenal spinal paraganglioma arising from the cauda equina.  It should not be confused with glomus coccygeum, a structure unrelated to paraganglia.  Clinically, it may be asymptomatic or present with cauda equina syndrome, lower back pain, or leg pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cauda Equina Neuroendocrine Tumor","conceptCode":"C5324","definition":"A slow-growing, well-differentiated neuroendocrine neoplasm arising from the cauda equina.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D938-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA09-1CE0-E034-0003BA3F9857","beginDate":"2004-03-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Perineurioma, intraneural variant","valueDescription":"Perineurioma, intraneural variant","ValueMeaning":{"publicId":"2573005","version":"1","preferredName":"Perineurioma, intraneural variant","longName":"2573005","preferredDefinition":"Perineurioma, intraneural variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA3A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA0A-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Perineurioma, soft tissue variant","valueDescription":"Perineurioma, soft tissue variant","ValueMeaning":{"publicId":"2573007","version":"1","preferredName":"Perineurioma, soft tissue variant","longName":"2573007","preferredDefinition":"Perineurioma, soft tissue variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA3C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA0C-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pilocytic astrocytoma","valueDescription":"Pilocytic astrocytoma","ValueMeaning":{"publicId":"2578708","version":"1","preferredName":"Pilocytic astrocytoma","longName":"2578708","preferredDefinition":"Pilocytic Astrocytoma, the most common glioma in children, is a WHO grade I astrocytic tumor. It is a generally well circumscribed, slowly growing, often cystic, astrocytoma. It is histologically characterized by a biphasic pattern with varying proportion of compacted bipolar cells which may have Rosenthal fibers (tapered corkscrew-shaped, brightly eosinophilic, intracytoplasmic hyaline masses) and loose textured multipolar cells with microcysts and granular bodies. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pilocytic Astrocytoma","conceptCode":"C4047","definition":"A WHO grade 1, relatively circumscribed, slowly growing, often cystic astrocytoma occurring in children and young adults.  Histologically it is characterized by a biphasic pattern with compacted bipolar cells associated with Rosenthal fibers and multipolar cells associated with microcysts and eosinophilic bodies/hyaline droplets. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0081-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA0D-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pineal parenchymal tumor of intermediate diff","valueDescription":"Pineal parenchymal tumor of intermediate differentiation","ValueMeaning":{"publicId":"2573008","version":"1","preferredName":"Pineal parenchymal tumor of intermediate differentiation","longName":"2573008","preferredDefinition":"Pineal parenchymal tumor of intermediate differentiation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA3D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA0E-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pineoblastoma","valueDescription":"Pineoblastoma","ValueMeaning":{"publicId":"2578700","version":"1","preferredName":"Pineoblastoma","longName":"2578700","preferredDefinition":"Pineoblastoma (WHO grade IV) is a highly malignant, primitive embryonal neoplasm, which occurs more commonly in children. It is composed of patternless sheets of densely packed small cells with round-to-irregular nuclei and scant cytoplasm, similar to medulloblastoma and related primitive neuroectodermal tumors. A frequent complication is metastasis via cerebrospinal fluid pathways, which is often associated with a fatal outcome. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pineoblastoma","conceptCode":"C9344","definition":"A poorly differentiated malignant embryonal neoplasm arising from the pineal region.  It usually occurs in children and it is characterized by the presence of small immature neuroepithelial cells.  It may follow an aggressive clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0079-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA0F-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pineocytoma","valueDescription":"Pineocytoma","ValueMeaning":{"publicId":"2578715","version":"1","preferredName":"Pineocytoma","longName":"2578715","preferredDefinition":"Pineocytoma (WHO grade II) is a slow growing tumor, more common in young adults. It is composed of small, uniform, mature cells resembling pineocytes with occasional large pineocytomatous rosettes.  It may show a wide range of divergent phenotypes, including neuronal, glial, melanocytic, photoreceptor and mesenchymal differentiation. Pineocytoma generally has a relatively favorable prognosis. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pineocytoma","conceptCode":"C6966","definition":"A WHO grade 1 slow growing tumor, more frequently affecting young adults. It is composed of small, uniform, mature cells resembling pineocytes with occasional large pineocytomatous rosettes. It may show a wide range of divergent phenotypes, including neuronal, glial, melanocytic, photoreceptor and mesenchymal differentiation. Pineocytoma generally has a relatively favorable prognosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0088-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA10-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Plasmacytoma","valueDescription":"plasmacytoma","ValueMeaning":{"publicId":"2568485","version":"1","preferredName":"plasmacytoma","longName":"2568485","preferredDefinition":"plasmacytoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D892-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA12-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pleomorphic xanthoastrocytoma","valueDescription":"Pleomorphic Xanthoastrocytoma","ValueMeaning":{"publicId":"2578698","version":"1","preferredName":"Pleomorphic Xanthoastrocytoma","longName":"2578698","preferredDefinition":"Pleomorphic Xanthoastrocytoma is an astrocytic tumor with a relatively favorable prognosis (WHO grade II) and is typically encountered in children and young adults. It has a superficial location in the cerebral hemispheres and involvement of the meninges. Characteristic features include pleomorphic and lipidized cells expressing GFAP and often surrounded by a reticulin network as well as eosinophilic granular bodies. For lesions with significant mitotic activity (5 or more mitoses per 10 HPF) and/or with areas of necrosis, the designation \"pleomorphic xanthoastrocytoma with anaplastic features\" may be used. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleomorphic Xanthoastrocytoma","conceptCode":"C4323","definition":"A WHO grade 2 astrocytic tumor with a relatively favorable prognosis.  It is characterized by pleomorphic and lipidized cells expressing GFAP often surrounded by a reticulin network and eosinophilic granular bodies. It presents in the superficial cerebral hemispheres and involves the meninges. It typically affects children and young adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0077-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA14-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Primary CNS lymphoma","valueDescription":"Primary Central Nervous System lymphoma","ValueMeaning":{"publicId":"2573010","version":"1","preferredName":"Primary Central Nervous System lymphoma","longName":"2573010","preferredDefinition":"Primary Central Nervous System lymphoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA3F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA15-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Rhabdomyoma","valueDescription":"Rhabdomyoma","ValueMeaning":{"publicId":"2573011","version":"1","preferredName":"Rhabdomyoma","longName":"2573011","preferredDefinition":"Rhabdomyoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA40-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA16-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Rhabdomysarcoma","valueDescription":"Rhabdomysarcoma","ValueMeaning":{"publicId":"2573012","version":"1","preferredName":"Rhabdomysarcoma","longName":"2573012","preferredDefinition":"Rhabdomysarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA41-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA17-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Schwannoma, cellular variant","valueDescription":"Schwannoma, cellular variant","ValueMeaning":{"publicId":"2573013","version":"1","preferredName":"Schwannoma, cellular variant","longName":"2573013","preferredDefinition":"Schwannoma, cellular variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA42-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA18-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Astrocytic tumor, NOS","valueDescription":"Astrocytic tumor, NOS","ValueMeaning":{"publicId":"2573049","version":"1","preferredName":"Astrocytic tumor, NOS","longName":"2573049","preferredDefinition":"Astrocytic tumor, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA66-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-1010-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Brainstem glioma, NOS","valueDescription":"Brainstem glioma, NOS","ValueMeaning":{"publicId":"2573050","version":"1","preferredName":"Brainstem glioma, NOS","longName":"2573050","preferredDefinition":"Brainstem glioma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA67-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-1011-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Craniopharyngioma, NOS","valueDescription":"Craniopharyngioma, NOS","ValueMeaning":{"publicId":"2573051","version":"1","preferredName":"Craniopharyngioma, NOS","longName":"2573051","preferredDefinition":"Craniopharyngioma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA68-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-1012-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Diffuse astrocytoma, NOS","valueDescription":"Diffuse astrocytoma, NOS","ValueMeaning":{"publicId":"2573052","version":"1","preferredName":"Diffuse astrocytoma, NOS","longName":"2573052","preferredDefinition":"Diffuse astrocytoma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA69-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-1013-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Embryonal tumor, NOS","valueDescription":"Embryonal tumor, NOS","ValueMeaning":{"publicId":"2573053","version":"1","preferredName":"Embryonal tumor, NOS","longName":"2573053","preferredDefinition":"Embryonal tumor, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA6A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-1014-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ependymoma, NOS","valueDescription":"Ependymoma, NOS","ValueMeaning":{"publicId":"2573054","version":"1","preferredName":"Ependymoma, NOS","longName":"2573054","preferredDefinition":"A WHO grade II, slow growing tumor of children and young adults, usually located intraventricularly. It is the most common ependymal neoplasm. It often causes clinical symptoms by blocking cerebrospinal fluid pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ependymoma","conceptCode":"C3017","definition":"A WHO grade 2, slow growing tumor of children and young adults, usually located intraventricularly. It is the most common ependymal neoplasm. It often causes clinical symptoms by blocking cerebrospinal fluid pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA6B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"PWEST","dateModified":"2014-05-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-1015-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Glial tumor/Glioma, NOS","valueDescription":"Glial tumor/Glioma, NOS","ValueMeaning":{"publicId":"2573055","version":"1","preferredName":"Glial tumor/Glioma, NOS","longName":"2573055","preferredDefinition":"Glial tumor/Glioma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA6C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-1016-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Glioblastoma (multiforme), NOS","valueDescription":"Glioblastoma (multiforme), NOS","ValueMeaning":{"publicId":"2573056","version":"1","preferredName":"Glioblastoma (multiforme), NOS","longName":"2573056","preferredDefinition":"Glioblastoma (multiforme), NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA6D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-1017-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Malignant lymphoma, NOS","valueDescription":"Malignant lymphoma, NOS","ValueMeaning":{"publicId":"2573057","version":"1","preferredName":"Malignant lymphoma, NOS","longName":"2573057","preferredDefinition":"Malignant lymphoma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA6E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-1018-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"MPNST, NOS","valueDescription":"Malignant peripheral nerve sheath tumor (MPNST), NOS","ValueMeaning":{"publicId":"2573058","version":"1","preferredName":"Malignant peripheral nerve sheath tumor (MPNST), NOS","longName":"2573058","preferredDefinition":"Malignant peripheral nerve sheath tumor (MPNST), NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA6F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-1019-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medulloblastoma, NOS","valueDescription":"Medulloblastoma, NOS","ValueMeaning":{"publicId":"2573059","version":"1","preferredName":"Medulloblastoma, NOS","longName":"2573059","preferredDefinition":"Medulloblastoma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA70-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-101A-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningioma, NOS","valueDescription":"Meningioma, NOS","ValueMeaning":{"publicId":"2573060","version":"1","preferredName":"Meningioma, NOS","longName":"2573060","preferredDefinition":"A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade I tumors, and some are WHO grade II or III tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meningioma","conceptCode":"C3230","definition":"A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade 1 tumors, and some are WHO grade 2 or 3 tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA71-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"PWEST","dateModified":"2014-05-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-101B-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Metastatic tumor, NOS","valueDescription":"Metastatic tumor, NOS","ValueMeaning":{"publicId":"2573061","version":"1","preferredName":"Metastatic tumor, NOS","longName":"2573061","preferredDefinition":"Metastatic tumor, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA72-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-101C-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Neuroblastic tumor, NOS","valueDescription":"Neuroblastic tumor, NOS","ValueMeaning":{"publicId":"2573062","version":"1","preferredName":"Neuroblastic tumor, NOS","longName":"2573062","preferredDefinition":"Neuroblastic tumor, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA73-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFD9E98-101D-0048-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Neurofibroma, NOS","valueDescription":"Neurofibroma, NOS","ValueMeaning":{"publicId":"2573063","version":"1","preferredName":"Neurofibroma, NOS","longName":"2573063","preferredDefinition":"Neurofibroma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA74-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BD65-1CE0-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Neuronal and mixed neuronal-glial tumor, NOS","valueDescription":"Neuronal and mixed neuronal-glial tumor, NOS","ValueMeaning":{"publicId":"2573064","version":"1","preferredName":"Neuronal and mixed neuronal-glial tumor, NOS","longName":"2573064","preferredDefinition":"Neuronal and mixed neuronal-glial tumor, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA75-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BD66-1CE0-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Perineurioma, NOS","valueDescription":"Perineurioma, NOS","ValueMeaning":{"publicId":"2573065","version":"1","preferredName":"Perineurioma, NOS","longName":"2573065","preferredDefinition":"Perineurioma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA76-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BD67-1CE0-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pituitary adenoma, NOS","valueDescription":"Pituitary adenoma, NOS","ValueMeaning":{"publicId":"2573066","version":"1","preferredName":"Pituitary adenoma, NOS","longName":"2573066","preferredDefinition":"Pituitary adenoma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA77-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BD68-1CE0-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Schwannoma (Neurilemmoma/Neurinoma), NOS","valueDescription":"Schwannoma (Neurilemmoma/Neurinoma), NOS","ValueMeaning":{"publicId":"2573067","version":"1","preferredName":"Schwannoma (Neurilemmoma/Neurinoma), NOS","longName":"2573067","preferredDefinition":"Schwannoma (Neurilemmoma/Neurinoma), NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA78-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BD69-1CE0-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"PNET, NOS","valueDescription":"Supratentorial primitive neuroectodermal tumor (PNET), NOS","ValueMeaning":{"publicId":"2573068","version":"1","preferredName":"Supratentorial primitive neuroectodermal tumor (PNET), NOS","longName":"2573068","preferredDefinition":"Supratentorial primitive neuroectodermal tumor (PNET), NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA79-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BD6A-1CE0-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Teratoma, NOS","valueDescription":"Teratoma, NOS","ValueMeaning":{"publicId":"2573069","version":"1","preferredName":"Teratoma, NOS","longName":"2573069","preferredDefinition":"Teratoma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA7A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BD6B-1CE0-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Teratoma, variant","valueDescription":"Teratoma, variant","ValueMeaning":{"publicId":"2573070","version":"1","preferredName":"Teratoma, variant","longName":"2573070","preferredDefinition":"Teratoma, variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA7B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"MAESKEB","dateModified":"2005-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BD6C-1CE0-E034-0003BA3F9857","beginDate":"2005-02-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Schwannoma, melanotic variant","valueDescription":"Schwannoma, melanotic variant","ValueMeaning":{"publicId":"2573014","version":"1","preferredName":"Schwannoma, melanotic variant","longName":"2573014","preferredDefinition":"Schwannoma, melanotic variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA43-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA19-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Schwannoma, plexiform variant","valueDescription":"Schwannoma, plexiform variant","ValueMeaning":{"publicId":"2573015","version":"1","preferredName":"Schwannoma, plexiform variant","longName":"2573015","preferredDefinition":"Schwannoma, plexiform variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA44-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA1A-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Solitary fibrous tumor","valueDescription":"Solitary fibrous tumor","ValueMeaning":{"publicId":"2573016","version":"1","preferredName":"Solitary fibrous tumor","longName":"2573016","preferredDefinition":"Solitary fibrous tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA45-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA1B-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Subependymal giant cell astrocytoma","valueDescription":"Subependymal giant cell astrocytoma","ValueMeaning":{"publicId":"2573017","version":"1","preferredName":"Subependymal giant cell astrocytoma","longName":"2573017","preferredDefinition":"Subependymal Giant Cell Astrocytoma is a benign, slowly growing tumor (WHO grade I) typically arising in the wall of the lateral ventricles and composed of large ganglioid astrocytes. It is the most common CNS neoplasm in patients with Tuberous Sclerosis Complex and typically occurs during the first two decades of life. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subependymal Giant Cell Astrocytoma","conceptCode":"C3696","definition":"A benign, slowly growing tumor (WHO grade I) typically arising in the wall of the lateral ventricles and composed of large ganglioid astrocytes. It is the most common CNS neoplasm in patients with tuberous sclerosis complex and typically occurs during the first two decades of life. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA46-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA1C-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Subependymoma","valueDescription":"Subependymoma","ValueMeaning":{"publicId":"2578710","version":"1","preferredName":"Subependymoma","longName":"2578710","preferredDefinition":"Subependymoma (WHO grade I) is a benign, slow growing neoplasm which is typically attached to a ventricular wall. It is composed of glial tumor cell clusters embedded in an abundant fibrillary matrix with frequent microcystic change. Some lesions have the histological features of both subependymoma and ependymoma. It is often detected incidentally and has a very favorable prognosis. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subependymoma","conceptCode":"C3795","definition":"A benign, slow growing neoplasm which is typically attached to a ventricular wall. It is composed of glial tumor cell clusters embedded in an abundant fibrillary matrix with frequent microcystic change. Some lesions have the histological features of both subependymoma and ependymoma. It is often detected incidentally and has a very favorable prognosis. (Adapted from WHO.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0083-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA1D-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"PNET, ganglioneuroblastoma variant","valueDescription":"Supratentorial primitive neuroectodermal tumor (PNET), ganglioneuroblastoma variant","ValueMeaning":{"publicId":"2573018","version":"1","preferredName":"Supratentorial primitive neuroectodermal tumor (PNET), ganglioneuroblastoma variant","longName":"2573018","preferredDefinition":"Supratentorial primitive neuroectodermal tumor (PNET), ganglioneuroblastoma variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA47-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA1E-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"PNET, neuroblastoma variant","valueDescription":"Supratentorial primitive neuroectodermal tumor (PNET), neuroblastoma variant","ValueMeaning":{"publicId":"2573019","version":"1","preferredName":"Supratentorial primitive neuroectodermal tumor (PNET), neuroblastoma variant","longName":"2573019","preferredDefinition":"Supratentorial primitive neuroectodermal tumor (PNET), neuroblastoma variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA48-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA1F-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Teratoma with malignant transformation","valueDescription":"Teratoma with malignant transformation","ValueMeaning":{"publicId":"2573020","version":"1","preferredName":"Teratoma with malignant transformation","longName":"2573020","preferredDefinition":"Teratoma with malignant transformation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA49-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA21-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Teratoma, immature variant","valueDescription":"Teratoma, immature variant","ValueMeaning":{"publicId":"2573021","version":"1","preferredName":"Teratoma, immature variant","longName":"2573021","preferredDefinition":"Teratoma, immature variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA4A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA22-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Teratoma, mature variant","valueDescription":"Teratoma, mature variant","ValueMeaning":{"publicId":"2573022","version":"1","preferredName":"Teratoma, mature variant","longName":"2573022","preferredDefinition":"Teratoma, mature variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA4B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA23-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Yolk-sac tumor","valueDescription":"Yolk-sac tumor","ValueMeaning":{"publicId":"2573023","version":"1","preferredName":"Yolk-sac tumor","longName":"2573023","preferredDefinition":"Yolk-sac tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA4C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"MAESKEB","dateModified":"2005-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF21B628-BA25-1CE0-E034-0003BA3F9857","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Spindle cell oncocytoma of the adenohypophysis","valueDescription":"Spindle Cell Oncocytoma of the Adenohypophysis","ValueMeaning":{"publicId":"5043925","version":"1","preferredName":"Spindle Cell Oncocytoma of the Adenohypophysis","longName":"5043925","preferredDefinition":"A very rare, WHO grade I, non-endocrine neoplasm that arises in the anterior lobe of the pituitary gland and described in adults.  Its histogenesis is uncertain, although it has been suggested that it is derived from the folliculo-stellate cells of the adenohypophysis.  It is characterized by the presence of spindle cells with eosinophilic, granular cytoplasm forming fascicles.  Electron microscopic studies demonstrate the accumulation of intracytoplasmic mitochondria and lack of secretory granules.  Immunohistochemical studies are negative for pituitary hormones.  Patients may present with pituitary hypofunction, visual disturbances, headache, nausea and vomiting.  The clinical course is usually benign.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spindle Cell Oncocytoma","conceptCode":"C94537","definition":"A very rare, WHO grade 1 neoplasm of the posterior pituitary. It is characterized by the presence of spindle cells with eosinophilic, granular cytoplasm forming fascicles.  Electron microscopic studies demonstrate the accumulation of intracytoplasmic mitochondria and lack of secretory granules.  Immunohistochemical studies are negative for pituitary hormones.  Patients may present with pituitary hypofunction, visual disturbances, headache, nausea and vomiting.  The clinical course is usually benign.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2436996F-9B22-D051-E050-BB89AD432085","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2436996F-9B3B-D051-E050-BB89AD432085","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Solitary fibrous histiocytoma","valueDescription":"Single Fibrohistiocytic Neoplasm","ValueMeaning":{"publicId":"5043926","version":"1","preferredName":"Single Fibrohistiocytic Neoplasm","longName":"5043926","preferredDefinition":"Not accompanied by another or others; exclusive of anyone or anything else.: A benign or malignant neoplasm composed of fibrohistiocytic cells, spindle fibrocytic cells, and histiocytes, in a storiform pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fibrohistiocytic Neoplasm","conceptCode":"C8402","definition":"A benign, intermediate, or malignant mesenchymal neoplasm composed of fibrohistiocytic cells, spindle fibroblastic cells, and histiocytes, in a storiform pattern.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2436996F-9B48-D051-E050-BB89AD432085","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2436996F-9B61-D051-E050-BB89AD432085","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Rosette-forming glioneuronal tumor of the fourth ventricle","valueDescription":"Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle","ValueMeaning":{"publicId":"5043928","version":"1","preferredName":"Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle","longName":"5043928","preferredDefinition":"A recently described central nervous system neoplasm arising from the fourth ventricle.  It is characterized by the presence of neurocytes forming pseudorosettes and astrocytes which contain Rosenthal fibers. Cytologic atypia is minimal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle","conceptCode":"C67559","definition":"A central nervous system neoplasm arising from the fourth ventricle. It is characterized by the presence of neurocytes forming pseudorosettes and astrocytes which contain Rosenthal fibers. Cytologic atypia is minimal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2436996F-9B6E-D051-E050-BB89AD432085","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2436996F-9B87-D051-E050-BB89AD432085","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Pituicytoma","valueDescription":"Pituicytoma","ValueMeaning":{"publicId":"5043929","version":"1","preferredName":"Pituicytoma","longName":"5043929","preferredDefinition":"An extremely rare, WHO grade I, circumscribed and slow-growing tumor that arises from the neurohypophysis or infundibulum and described in adults.  It is characterized by the presence of elongated, spindle-shaped neoplastic glial cells that form storiform patterns or interlacing fascicular arrangements.  Signs and symptoms include visual disturbances, headache, amenorrhea, and decreased libido.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pituicytoma","conceptCode":"C94524","definition":"An extremely rare, WHO grade 1, circumscribed and slow-growing tumor that arises from the neurohypophysis or infundibulum and described in adults.  It is characterized by the presence of elongated, spindle-shaped neoplastic glial cells that form storiform patterns or interlacing fascicular arrangements.  Signs and symptoms include visual disturbances, headache, amenorrhea, and decreased libido.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2436996F-9B93-D051-E050-BB89AD432085","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2436996F-9BAC-D051-E050-BB89AD432085","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Pilomyxoid Astrocytoma","valueDescription":"Pilomyxoid Astrocytoma","ValueMeaning":{"publicId":"5043930","version":"1","preferredName":"Pilomyxoid Astrocytoma","longName":"5043930","preferredDefinition":"An astrocytic tumor of uncertain relation to pilocytic astrocytoma.  It occurs predominantly in infants and young children.  It is characterized by a monomorphic architectural pattern, usually associated with the absence of Rosenthal fibers and eosinophilic granular bodies.  The clinical course is usually aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pilomyxoid Astrocytoma","conceptCode":"C40315","definition":"An astrocytic tumor of uncertain relation to pilocytic astrocytoma.  It occurs predominantly in infants and young children.  It is characterized by a monomorphic architectural pattern, usually associated with the absence of Rosenthal fibers and eosinophilic granular bodies.  The clinical course is usually aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2436996F-9BB8-D051-E050-BB89AD432085","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2436996F-9BD1-D051-E050-BB89AD432085","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Papillary Tumor of the Pineal Region","valueDescription":"Papillary Tumor of the Pineal Region","ValueMeaning":{"publicId":"5043931","version":"1","preferredName":"Papillary Tumor of the Pineal Region","longName":"5043931","preferredDefinition":"A rare tumor that arises from the pineal region and affects adults.  It is characterized by the presence of neuroepithelial cells and a papillary architecture.  Electron microscopic studies suggest ependymal differentiation.  The clinical course is variable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Tumor of the Pineal Region","conceptCode":"C92624","definition":"A rare tumor that arises from the pineal region and affects adults.  It is characterized by the presence of neuroepithelial cells and a papillary architecture.  Electron microscopic studies suggest ependymal differentiation.  The clinical course is variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2436996F-9BDD-D051-E050-BB89AD432085","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2436996F-9BF6-D051-E050-BB89AD432085","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Papillary Glioneuronal Tumor","valueDescription":"Papillary Glioneuronal Tumor","ValueMeaning":{"publicId":"5043932","version":"1","preferredName":"Papillary Glioneuronal Tumor","longName":"5043932","preferredDefinition":"A WHO grade I, indolent and relatively circumscribed brain tumor.  Morphologically it is characterized by the presence of astrocytes that line vascular and hyalinized pseudopapillae.  In between the pseudopapillae aggregates of neurocytes, large neurons, and ganglioid cells are present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Glioneuronal Tumor","conceptCode":"C92554","definition":"A WHO grade 1, indolent and relatively circumscribed brain tumor.  Morphologically it is characterized by the presence of astrocytes that line vascular and hyalinized pseudopapillae.  In between the pseudopapillae aggregates of neurocytes, large neurons, and ganglioid cells are present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2436996F-9C02-D051-E050-BB89AD432085","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2436996F-9C1B-D051-E050-BB89AD432085","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Osteochondroma","valueDescription":"Osteochondroma","ValueMeaning":{"publicId":"3251712","version":"1","preferredName":"Osteochondroma","longName":"3251712","preferredDefinition":"A common, benign cartiliginous neoplasm arising from the metaphysis of bone. The tumor grows on the surface of the bone; it may be pedunculated or sessile. It is characterized by the presence of chondrocytes, a cartilage cap, and a fibrous perichondrium that extends to the periosteum of the bone. In some cases, there is deletion of 8q24.1 chromosome locus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteochondroma","conceptCode":"C3295","definition":"A common, benign cartiliginous neoplasm arising from the metaphysis of bone. The tumor grows on the surface of the bone; it may be pedunculated or sessile. It is characterized by the presence of chondrocytes, a cartilage cap, and a fibrous perichondrium that extends to the periosteum of the bone. In some cases, there is deletion of 8q24.1 chromosome locus.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7696A98-D666-85AE-E040-BB89AD433885","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2436996F-9C25-D051-E050-BB89AD432085","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Angiocentric Glioma","valueDescription":"Angiocentric Glioma","ValueMeaning":{"publicId":"5043584","version":"1","preferredName":"Angiocentric Glioma","longName":"5043584","preferredDefinition":"A WHO grade I, slow-growing brain neoplasm of children and young adults, associated with epilepsy.  Morphologically it is characterized by an angiocentric pattern, monomorphic cellular infiltrate, and ependymal differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angiocentric Glioma","conceptCode":"C92552","definition":"A WHO grade 1, slow-growing brain neoplasm of children and young adults, associated with epilepsy.  Morphologically it is characterized by an angiocentric pattern, monomorphic cellular infiltrate, and ependymal differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24332DE1-1043-F0BF-E050-BB89AD4319C0","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24332DE1-105C-F0BF-E050-BB89AD4319C0","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Anaplastic Medulloblastoma","valueDescription":"Anaplastic Medulloblastoma","ValueMeaning":{"publicId":"3251358","version":"1","preferredName":"Anaplastic Medulloblastoma","longName":"3251358","preferredDefinition":"A medulloblastoma characterized by marked nuclear pleomorphism, and high mitotic activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Medulloblastoma","conceptCode":"C92625","definition":"A medulloblastoma characterized by marked nuclear pleomorphism, and high mitotic activity.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-9F5F-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24332DE1-1070-F0BF-E050-BB89AD4319C0","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Anaplastic (Malignant) Meningioma","valueDescription":"Anaplastic (Malignant) Meningioma","ValueMeaning":{"publicId":"5043585","version":"1","preferredName":"Anaplastic (Malignant) Meningioma","longName":"5043585","preferredDefinition":"A WHO grade III meningioma characterized by the presence of malignant morphologic features, including malignant cytology and a very high mitotic index (20 or more mitoses per ten high power fields).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic (Malignant) Meningioma","conceptCode":"C4051","definition":"A WHO grade III meningioma characterized by the presence of malignant morphologic features, including malignant cytology and a very high mitotic index (20 or more mitoses per ten high power fields).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24332DE1-107A-F0BF-E050-BB89AD4319C0","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24332DE1-1092-F0BF-E050-BB89AD4319C0","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Epithelioid","valueDescription":"Epithelioid Cell","ValueMeaning":{"publicId":"4264822","version":"1","preferredName":"Epithelioid Cell","longName":"4264822","preferredDefinition":"Characteristic cells of granulomatous hypersensitivity. They appear as large, flattened cells with increased endoplasmic reticulum. They are believed to be activated macrophages that have differentiated as a result of prolonged antigenic stimulation. Further differentiation or fusion of epithelioid cells is thought to produce multinucleated giant cells. (MeSH)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Cell","conceptCode":"C12559","definition":"A cell of mononuclear phagocyte system origin that resembles an epithelial cell and is involved in immune granuloma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FD49-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24345169-34D4-3953-E050-BB89AD434EF8","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Diffuse glioma","valueDescription":"Diffuse Glioma","ValueMeaning":{"publicId":"5043619","version":"1","preferredName":"Diffuse Glioma","longName":"5043619","preferredDefinition":"widely spread; not localized or confined.: A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse","conceptCode":"C14175","definition":"Widely spread; not localized or confined.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Glioma","conceptCode":"C3059","definition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24345169-34E2-3953-E050-BB89AD434EF8","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24345169-34FB-3953-E050-BB89AD434EF8","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Desmoplastic/Nodular Medulloblastoma","valueDescription":"Desmoplastic/Nodular Medulloblastoma","ValueMeaning":{"publicId":"5043620","version":"1","preferredName":"Desmoplastic/Nodular Medulloblastoma","longName":"5043620","preferredDefinition":"A medulloblastoma characterized by the presence of nodular, collagenous areas which do not contain reticulin, surrounded by hypercellular areas which contain an intercellular reticulin fiber network.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic/Nodular Medulloblastoma","conceptCode":"C4956","definition":"A medulloblastoma characterized by the presence of nodular, collagenous areas which do not contain reticulin, surrounded by hypercellular areas which contain an intercellular reticulin fiber network.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24345169-3505-3953-E050-BB89AD434EF8","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24345169-351E-3953-E050-BB89AD434EF8","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"CNS PNET, NOS","valueDescription":"Central Nervous System Not Otherwise Specified Primitive Neuroectodermal Tumor","ValueMeaning":{"publicId":"5043621","version":"1","preferredName":"Central Nervous System Not Otherwise Specified Primitive Neuroectodermal Tumor","longName":"5043621","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.: Not characterized in any other way.: A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Primitive Neuroectodermal Tumor","conceptCode":"C3716","definition":"A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24345169-352C-3953-E050-BB89AD434EF8","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24345169-3545-3953-E050-BB89AD434EF8","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"CNS neuroblastoma","valueDescription":"Central Nervous System Neuroblastoma","ValueMeaning":{"publicId":"5043622","version":"1","preferredName":"Central Nervous System Neuroblastoma","longName":"5043622","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.: A neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neuroblastoma","conceptCode":"C3270","definition":"A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24345169-3552-3953-E050-BB89AD434EF8","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24345169-356B-3953-E050-BB89AD434EF8","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"CNS Ganglioneuroblastoma","valueDescription":"Cerebral Ganglioneuroblastoma","ValueMeaning":{"publicId":"5043624","version":"1","preferredName":"Cerebral Ganglioneuroblastoma","longName":"5043624","preferredDefinition":"A supratentorial primitive neuroectodermal tumor characterized by the presence of poorly differentiated or undifferentiated neuroepithelial cells and ganglion cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Ganglioneuroblastoma","conceptCode":"C92629","definition":"A malignant central nervous system neoplasm characterized by the presence of poorly differentiated or undifferentiated neuroepithelial cells and ganglion cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24345169-3578-3953-E050-BB89AD434EF8","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24345169-3591-3953-E050-BB89AD434EF8","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Atypical Teratoid/Rhabdoid Tumor","valueDescription":"Atypical Teratoid/Rhabdoid Tumor","ValueMeaning":{"publicId":"4722554","version":"1","preferredName":"Atypical Teratoid/Rhabdoid Tumor","longName":"4722554","preferredDefinition":"An aggressive malignant embryonal neoplasm arising from the central nervous system.  It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm.  It may be associated with loss of chromosome 22.  The vast majority of cases occur in childhood.  Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Teratoid/Rhabdoid Tumor","conceptCode":"C6906","definition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. Mutations of the SMARCB1 gene or very rarely SMARCA4 (BRG1) gene are present. The vast majority of cases occur in childhood. Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B6B7-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SOKKERL","dateModified":"2024-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24345169-35A5-3953-E050-BB89AD434EF8","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Atypical choroid plexus papilloma","valueDescription":"Atypical Choroid Plexus Papilloma","ValueMeaning":{"publicId":"5043625","version":"1","preferredName":"Atypical Choroid Plexus Papilloma","longName":"5043625","preferredDefinition":"Varying from the norm; not conformable to the type.: A benign, slow growing tumor which may cause symptoms by blocking cerebrospinal fluid pathways.  It is characterized by the presence of delicate fibrovascular connective tissue fronds covered by a single layer of epithelial cells.  Mitotic activity is extremely low.  Surgical resection is usually curative. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical","conceptCode":"C25428","definition":"Varying from the norm; not conformable to the type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Choroid Plexus Papilloma","conceptCode":"C3698","definition":"A benign, slow growing tumor which may cause symptoms by blocking cerebrospinal fluid pathways.  It is characterized by the presence of delicate fibrovascular connective tissue fronds covered by a single layer of epithelial cells.  Mitotic activity is extremely low.  Surgical resection is usually curative. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24345169-35B2-3953-E050-BB89AD434EF8","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24345169-35CB-3953-E050-BB89AD434EF8","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Epithelioid hemangioendothelioma","valueDescription":"Epithelioid hemangioendothelioma","ValueMeaning":{"publicId":"5043626","version":"1","preferredName":"Epithelioid hemangioendothelioma","longName":"5043626","preferredDefinition":"Epitheliod hemangioendothelioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24345169-35D5-3953-E050-BB89AD434EF8","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24345169-35EE-3953-E050-BB89AD434EF8","beginDate":"2005-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Metastatic pituicytoma","valueDescription":"Metastatic Pituicytoma","ValueMeaning":{"publicId":"5043689","version":"1","preferredName":"Metastatic Pituicytoma","longName":"5043689","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: An extremely rare, WHO grade I, circumscribed and slow-growing tumor that arises from the neurohypophysis or infundibulum and described in adults.  It is characterized by the presence of elongated, spindle-shaped neoplastic glial cells that form storiform patterns or interlacing fascicular arrangements.  Signs and symptoms include visual disturbances, headache, amenorrhea, and decreased libido.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pituicytoma","conceptCode":"C94524","definition":"An extremely rare, WHO grade 1, circumscribed and slow-growing tumor that arises from the neurohypophysis or infundibulum and described in adults.  It is characterized by the presence of elongated, spindle-shaped neoplastic glial cells that form storiform patterns or interlacing fascicular arrangements.  Signs and symptoms include visual disturbances, headache, amenorrhea, and decreased libido.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24342D80-6A60-16D6-E050-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24342D80-6A79-16D6-E050-BB89AD4321A1","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Metastatic pilomyxoid astrocytoma","valueDescription":"Metastatic Pilomyxoid Astrocytoma","ValueMeaning":{"publicId":"5043691","version":"1","preferredName":"Metastatic Pilomyxoid Astrocytoma","longName":"5043691","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: An astrocytic tumor of uncertain relation to pilocytic astrocytoma.  It occurs predominantly in infants and young children.  It is characterized by a monomorphic architectural pattern, usually associated with the absence of Rosenthal fibers and eosinophilic granular bodies.  The clinical course is usually aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pilomyxoid Astrocytoma","conceptCode":"C40315","definition":"An astrocytic tumor of uncertain relation to pilocytic astrocytoma.  It occurs predominantly in infants and young children.  It is characterized by a monomorphic architectural pattern, usually associated with the absence of Rosenthal fibers and eosinophilic granular bodies.  The clinical course is usually aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24342D80-6A87-16D6-E050-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24342D80-6AA0-16D6-E050-BB89AD4321A1","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Metastatic papillary tumor of the pineal region (PTPR)","valueDescription":"Metastatic Papillary Tumor of the Pineal Region","ValueMeaning":{"publicId":"5043693","version":"1","preferredName":"Metastatic Papillary Tumor of the Pineal Region","longName":"5043693","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: A rare tumor that arises from the pineal region and affects adults.  It is characterized by the presence of neuroepithelial cells and a papillary architecture.  Electron microscopic studies suggest ependymal differentiation.  The clinical course is variable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Papillary Tumor of the Pineal Region","conceptCode":"C92624","definition":"A rare tumor that arises from the pineal region and affects adults.  It is characterized by the presence of neuroepithelial cells and a papillary architecture.  Electron microscopic studies suggest ependymal differentiation.  The clinical course is variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24342D80-6AAE-16D6-E050-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24342D80-6AC7-16D6-E050-BB89AD4321A1","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Metastatic papillary glioneuronal tumor (PGNT)","valueDescription":"Metastatic Papillary Glioneuronal Tumor","ValueMeaning":{"publicId":"5043695","version":"1","preferredName":"Metastatic Papillary Glioneuronal Tumor","longName":"5043695","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: A WHO grade I, indolent and relatively circumscribed brain tumor.  Morphologically it is characterized by the presence of astrocytes that line vascular and hyalinized pseudopapillae.  In between the pseudopapillae aggregates of neurocytes, large neurons, and ganglioid cells are present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Papillary Glioneuronal Tumor","conceptCode":"C92554","definition":"A WHO grade 1, indolent and relatively circumscribed brain tumor.  Morphologically it is characterized by the presence of astrocytes that line vascular and hyalinized pseudopapillae.  In between the pseudopapillae aggregates of neurocytes, large neurons, and ganglioid cells are present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24342D80-6AD5-16D6-E050-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24342D80-6AEE-16D6-E050-BB89AD4321A1","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Metastatic angiocentric glioma","valueDescription":"Metastatic Angiocentric Glioma","ValueMeaning":{"publicId":"5043696","version":"1","preferredName":"Metastatic Angiocentric Glioma","longName":"5043696","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: A WHO grade I, slow-growing brain neoplasm of children and young adults, associated with epilepsy.  Morphologically it is characterized by an angiocentric pattern, monomorphic cellular infiltrate, and ependymal differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Angiocentric Glioma","conceptCode":"C92552","definition":"A WHO grade 1, slow-growing brain neoplasm of children and young adults, associated with epilepsy.  Morphologically it is characterized by an angiocentric pattern, monomorphic cellular infiltrate, and ependymal differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24342D80-6AFB-16D6-E050-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24342D80-6B14-16D6-E050-BB89AD4321A1","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Melanotic","valueDescription":"Melanotic","ValueMeaning":{"publicId":"2575128","version":"1","preferredName":"Melanotic","longName":"2575128","preferredDefinition":"Melanotic","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F285-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-24","modifiedBy":"REEVESD","dateModified":"2005-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"245B04F1-1E69-531F-E050-BB89AD43730E","beginDate":"2015-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-12","modifiedBy":"ONEDATA","dateModified":"2015-11-12","deletedIndicator":"No"},{"value":"Metastatic spindle cell oncocytoma (SCO)","valueDescription":"Metastatic Spindle Cell Oncocytoma of the Adenohypophysis","ValueMeaning":{"publicId":"5043934","version":"1","preferredName":"Metastatic Spindle Cell Oncocytoma of the Adenohypophysis","longName":"5043934","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: A very rare, WHO grade I, non-endocrine neoplasm that arises in the anterior lobe of the pituitary gland and described in adults.  Its histogenesis is uncertain, although it has been suggested that it is derived from the folliculo-stellate cells of the adenohypophysis.  It is characterized by the presence of spindle cells with eosinophilic, granular cytoplasm forming fascicles.  Electron microscopic studies demonstrate the accumulation of intracytoplasmic mitochondria and lack of secretory granules.  Immunohistochemical studies are negative for pituitary hormones.  Patients may present with pituitary hypofunction, visual disturbances, headache, nausea and vomiting.  The clinical course is usually benign.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Spindle Cell Oncocytoma","conceptCode":"C94537","definition":"A very rare, WHO grade 1 neoplasm of the posterior pituitary. It is characterized by the presence of spindle cells with eosinophilic, granular cytoplasm forming fascicles.  Electron microscopic studies demonstrate the accumulation of intracytoplasmic mitochondria and lack of secretory granules.  Immunohistochemical studies are negative for pituitary hormones.  Patients may present with pituitary hypofunction, visual disturbances, headache, nausea and vomiting.  The clinical course is usually benign.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24358069-7FE0-949E-E050-BB89AD436C96","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24358069-7FF9-949E-E050-BB89AD436C96","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Metastatic rosette-forming glioneuronal tumor of the fourth ventricle (RGNT)","valueDescription":"Metastatic Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle","ValueMeaning":{"publicId":"5043938","version":"1","preferredName":"Metastatic Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle","longName":"5043938","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: A recently described central nervous system neoplasm arising from the fourth ventricle.  It is characterized by the presence of neurocytes forming pseudorosettes and astrocytes which contain Rosenthal fibers. Cytologic atypia is minimal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle","conceptCode":"C67559","definition":"A central nervous system neoplasm arising from the fourth ventricle. It is characterized by the presence of neurocytes forming pseudorosettes and astrocytes which contain Rosenthal fibers. Cytologic atypia is minimal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24358069-8007-949E-E050-BB89AD436C96","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24358069-8020-949E-E050-BB89AD436C96","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Meningothelial","valueDescription":"Meningothelial Cell","ValueMeaning":{"publicId":"5043639","version":"1","preferredName":"Meningothelial Cell","longName":"5043639","preferredDefinition":"The cellular components of the meninges.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meningothelial Cell","conceptCode":"C33095","definition":"The cellular components of the meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2434C622-BE2D-E3B1-E050-BB89AD43792A","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2434C622-BE46-E3B1-E050-BB89AD43792A","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Medulloblastoma with Extensive Nodularity","valueDescription":"Medulloblastoma with Extensive Nodularity","ValueMeaning":{"publicId":"5043640","version":"1","preferredName":"Medulloblastoma with Extensive Nodularity","longName":"5043640","preferredDefinition":"A medulloblastoma characterized by nodularity and neuronal differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma with Extensive Nodularity","conceptCode":"C5407","definition":"A medulloblastoma characterized by nodularity and neuronal differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2434C622-BE52-E3B1-E050-BB89AD43792A","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2434C622-BE6B-E3B1-E050-BB89AD43792A","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Gliosarcoma","valueDescription":"Gliosarcoma","ValueMeaning":{"publicId":"2578705","version":"1","preferredName":"Gliosarcoma","longName":"2578705","preferredDefinition":"A rare histological variant of glioblastoma (WHO grade IV) characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (WHO).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gliosarcoma","conceptCode":"C3796","definition":"A rare histological variant of glioblastoma (WHO grade IV) characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (WHO).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2434C622-BE75-E3B1-E050-BB89AD43792A","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Glioma, unclassified anaplastic","valueDescription":"Unclassified Anaplastic Glioma","ValueMeaning":{"publicId":"5043641","version":"1","preferredName":"Unclassified Anaplastic Glioma","longName":"5043641","preferredDefinition":"Not arranged or included in any specific grouping.: A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.: A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unclassified","conceptCode":"C64486","definition":"Not arranged or included in any specific grouping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Anaplastic","conceptCode":"C14144","definition":"A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Glioma","conceptCode":"C3059","definition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2434C622-BE83-E3B1-E050-BB89AD43792A","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2434C622-BE9C-E3B1-E050-BB89AD43792A","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"},{"value":"Glioma, unclassified","valueDescription":"Glioma","ValueMeaning":{"publicId":"5043642","version":"1","preferredName":"Glioma","longName":"5043642","preferredDefinition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioma","conceptCode":"C3059","definition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2434C622-BEA6-E3B1-E050-BB89AD43792A","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2434C622-BEBF-E3B1-E050-BB89AD43792A","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFD9E98-0107-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2016-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2190530","version":"1","longName":"Demonstration Applications","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812349","version":"1","longName":"Rembrandt","context":"NCIP"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"NCIP"}],"ReferenceDocuments":[{"name":"Post-op Histologic Diagnosis","type":"Preferred Question Text","description":"Post-op Histologic Diagnosis","url":null,"context":"NCIP"}],"origin":"WHO:World Health Organization","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFD9E98-0144-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":"Released status approved by CCR on 2/5/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}